VIA Pharmaceuticals' Unattributed VC Round

VIA Pharmaceuticals raised a round of funding on August 13, 2007.

Drug development company targeting vascular inflammation. Using proprietary drug assessment tools, the company has established a screening system to identify drug candidates. VIA acquires anti-inflam…

Articles about VIA Pharmaceuticals' Unattributed VC Round: